3,595 Shares in CME Group Inc. $CME Bought by Midwest Trust Co

Midwest Trust Co acquired a new stake in CME Group Inc. (NASDAQ:CME) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,595 shares of the financial services provider’s stock, valued at approximately $991,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in CME. Webster Bank N. A. lifted its stake in CME Group by 206.9% in the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after buying an additional 60 shares during the last quarter. Highline Wealth Partners LLC raised its position in CME Group by 84.3% in the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 43 shares during the last quarter. Trifecta Capital Advisors LLC boosted its stake in CME Group by 59.2% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock worth $31,000 after purchasing an additional 42 shares during the period. Ransom Advisory Ltd purchased a new position in CME Group during the 1st quarter worth $31,000. Finally, Westside Investment Management Inc. increased its stake in CME Group by 105.0% in the second quarter. Westside Investment Management Inc. now owns 123 shares of the financial services provider’s stock valued at $34,000 after purchasing an additional 63 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Buying and Selling

In related news, insider Timothy Francis Mccourt sold 379 shares of the business’s stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total value of $98,475.57. Following the completion of the sale, the insider directly owned 9,508 shares in the company, valued at approximately $2,470,463.64. The trade was a 3.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Harold Eugene Jr. Ford sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $263.53, for a total value of $263,530.00. Following the transaction, the director directly owned 1,091 shares in the company, valued at $287,511.23. This trade represents a 47.82% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 14,043 shares of company stock worth $3,791,486 in the last 90 days. 0.30% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. Deutsche Bank Aktiengesellschaft upgraded shares of CME Group from a “hold” rating to a “buy” rating and lifted their price objective for the company from $266.00 to $300.00 in a research report on Thursday, October 23rd. Raymond James Financial lowered their target price on shares of CME Group from $309.00 to $307.00 and set an “outperform” rating on the stock in a report on Monday, October 13th. JPMorgan Chase & Co. boosted their price target on shares of CME Group from $252.00 to $256.00 and gave the stock an “underweight” rating in a research note on Tuesday, October 14th. Rothschild & Co Redburn raised their price objective on shares of CME Group from $297.00 to $300.00 and gave the company a “neutral” rating in a research report on Thursday, November 6th. Finally, The Goldman Sachs Group raised their target price on CME Group from $262.00 to $263.00 and gave the company a “sell” rating in a report on Thursday, October 23rd. Eight analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $286.06.

CME Group Stock Up 0.6%

CME stock opened at $278.84 on Wednesday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The company’s 50 day simple moving average is $266.34 and its 200-day simple moving average is $272.60. CME Group Inc. has a 12 month low of $222.56 and a 12 month high of $290.79. The firm has a market capitalization of $100.55 billion, a PE ratio of 27.02, a P/E/G ratio of 4.41 and a beta of 0.38.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.63 by $0.05. The firm had revenue of $1.54 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a return on equity of 14.61% and a net margin of 58.84%.CME Group’s revenue was down 3.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.68 EPS. Equities analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 12th will be paid a $1.25 dividend. The ex-dividend date of this dividend is Friday, December 12th. This represents a $5.00 annualized dividend and a yield of 1.8%. CME Group’s payout ratio is presently 48.45%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.